IRIS
DEGLI UBERTI, Ettore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20292
EU - Europa 7416
AS - Asia 3613
Continente sconosciuto - Info sul continente non disponibili 18
SA - Sud America 9
OC - Oceania 3
AF - Africa 1
Totale 31352
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20273
DE - Germania 2450
CN - Cina 2430
UA - Ucraina 1935
TR - Turchia 1119
IT - Italia 811
GB - Regno Unito 605
SE - Svezia 466
FI - Finlandia 432
RU - Federazione Russa 342
PL - Polonia 153
FR - Francia 92
BE - Belgio 71
IR - Iran 24
IN - India 17
NL - Olanda 16
EU - Europa 14
CA - Canada 13
RO - Romania 10
VN - Vietnam 10
IE - Irlanda 6
MX - Messico 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CH - Svizzera 4
ES - Italia 4
PE - Perù 4
PT - Portogallo 4
AT - Austria 3
AU - Australia 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EC - Ecuador 2
IQ - Iraq 2
JP - Giappone 2
MD - Moldavia 2
AR - Argentina 1
BG - Bulgaria 1
CL - Cile 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
VE - Venezuela 1
Totale 31352
Salva come PNG Salva come JPEG
Città #
Woodbridge 3034
Fairfield 2463
Jacksonville 2164
Chandler 2083
Houston 1734
Ann Arbor 1271
Ashburn 954
Wilmington 954
Seattle 941
Cambridge 749
Izmir 677
Nanjing 618
Beijing 545
Princeton 440
Addison 384
San Diego 278
Boardman 263
Shenyang 198
Milan 195
Nanchang 180
Dearborn 163
Warsaw 152
Hebei 135
Ferrara 134
Changsha 112
Bremen 110
Tianjin 108
Jiaxing 97
Jinan 79
Falls Church 69
Mountain View 67
Brussels 65
San Mateo 62
Kunming 47
Norwalk 47
Ningbo 45
Redwood City 44
Washington 44
Zhengzhou 42
Carrara 40
Auburn Hills 36
Guangzhou 36
Helsinki 35
Taizhou 33
Leawood 30
Orange 28
Düsseldorf 27
Des Moines 26
Indiana 25
London 25
Hefei 24
Philadelphia 24
Augusta 22
Verona 20
Hangzhou 19
New York 19
Monmouth Junction 18
Ardabil 17
Lanzhou 15
Los Angeles 15
Shanghai 14
Changchun 13
Ferrara di Monte Baldo 12
Haikou 11
Redmond 10
Dong Ket 9
Chengdu 8
Mumbai 8
Walnut 8
Yellow Springs 8
Bologna 7
Padova 7
Rome 7
San Francisco 7
Chicago 6
Castelnuovo Rangone 5
Dallas 5
Fuzhou 5
Munich 5
Jinhua 4
Lima 4
Taiyuan 4
Waanrode 4
Andover 3
Caiazzo 3
Cordovado 3
Hebden Bridge 3
Montréal 3
Napoli 3
Pavia 3
Salerno 3
Santa Clara 3
Tappahannock 3
Tehran 3
Toronto 3
Baotou 2
Bollate 2
Brembate 2
Caldonazzo 2
Chisinau 2
Totale 22498
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 227
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 151
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 149
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 148
Igf-I influences everolimus activity in medullary thyroid carcinoma 146
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 144
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 142
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 140
Circadian profile of plasma calcitonin gene-related peptide in healthy man 136
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 136
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 132
null 130
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 129
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 128
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 128
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 128
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 127
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 127
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 124
Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide 122
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 121
Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure 118
Role of the serotonergic system in the genesis of vasovagal syncope. 118
null 118
ROLL technique application for Minimally-Invasive Radioguided Parathyroidectomy (MIRP) in Hyperparathyroidism (HPT) 118
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 117
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 117
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects 116
Cerebral aneurysm and acromegaly: a case report 115
Dermorphin, a new opioid peptide, stimulates thyrotropin secretion in normal subjects. 115
Characterization of a deleted Y chromosome in a male with Turner stigmata 115
null 114
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 114
Atrial strain is the main determinant of release of atrial natriuretic peptide 113
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 113
null 113
Pituitary side effects of old and new drugs. 113
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 113
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects 112
Post-partum thyroiditis-a clinical update. 112
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 112
null 111
In vitro testing of new somatostatin analogs on pituitary tumor cells 111
Stimulatory effect of dermorphin, a new synthetic potent opiate-like peptide, on human growth hormone secretion 111
null 111
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 110
Rare diseases in clinical endocrinology: a taxonomic classification system. 110
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. 110
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion. 109
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 109
null 108
null 106
null 106
null 106
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 106
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 106
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. 106
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine needle aspiration biopsies. 106
Effect of ketanserin, an inhibitor of 5-HT2 receptors, on the aldosterone-stimulating action of metoclopramide 106
Atrial natriuretic peptide and circadian blood pressure regulation: clues from a chronobiological approach 106
Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia 105
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 105
Different levels of thyroglobulin mRNA in normal and neoplastic human thyroids 105
Functional characterization of a new deletion in CDKN1B 5'-UTR region 105
null 105
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 105
Effect of dermorphin on behavior and hippocampal electrical activity in rabbits 104
Cholinergic mediation in dermorphin-induced growth hormone secretion in man 104
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 104
mTOR mediated IGF1 proliferative effects on a rat pituitary GH/PRL secreting pituitary adenoma cell line 104
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 103
null 103
null 102
null 102
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 102
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 102
null 102
null 101
null 101
Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure 101
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 101
Responses of plasma renin activity, aldosterone, adrenocorticotropin, and cortisol to dermorphin, a new synthetic potent opiate-like peptide, in man 101
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 101
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 101
null 100
Prolactin-releasing activity of dermorphin, a new synthetic potent opiate-like peptide, in normal human subjects. 100
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 100
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 100
Does placebo lower blood pressure in hypertensive patients? A noninvasive chronobiological study 99
Iodine excess and hyperthyroidism. 99
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 99
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 98
Dermorphin inhibits spinal nociceptive flexion reflex in humans 98
null 98
L’iperplasia surrenale congenita e la pubertà precoce 98
Prolactin and growth hormone responses to dermorphin in patients with prolactin-secreting pituitary adenoma 98
Retinoic acid-induced decrease of DNA synthesis and peroxidase mRNA levels in human thyroid cells expressing retinoic acid receptor alpha mRNA. 97
Circadian rhythms of atrial natriuretic peptide and blood pressure are consistently blunted in chronic renal failure 97
MicroRNAs and possible role in pituitary adenoma 97
Growth hormone and skeletal muscle function 97
Totale 11309
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59336
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3834
Totale 63170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018511 0000 00 00 034714321
2018/20195219 128128129215 18456 66442 4187508071698
2019/20206998 12481941901016 426886 548718 44982939698
2020/20214432 464385206588 164497 115522 68524689210
2021/20224093 130420246180 192186 165183 1643394381450
2022/20234044 444303175596 691660 200392 583000
Totale 31661